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Abstract Zinc ions were found to inhibit Ca2’ uptake by rat liver mitochondria driven by succinate respiration but not that by a valinomycin-induced 
membrane potential. Zn’+ at 1 PM or higher concentrations induced a lowering of the membrane potential under the former but not the latter 
conditions. It is concluded that it is the lowered membrane potential in the presence of Zn” that reduces the rate of respiration-driven Car’. Ruthenium 
red was found to inhibit the uptake of Zn2+ but had no influence on its action upon the membrane potential. Zn2’ did not affect he Ruthenium 
red-insensitive Ca’+ et&ix. Ca” stimulated the uptake of Zn 2+ . It is concluded that Zn” may be transported by the mitochondrial calcium uniporter 
but that it may have access to sites required for inhibition of respiration by other routes. 
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1. Introduction 
When administered in moderate amounts to rats in vivo, 
Zn” is accumulated mainly in the liver mitochondria where 
succinate dehydrogenase activity is increased [l]. Zn” was also 
found to stimulate the activity of cytochrome oxidase and to 
increase the level of ATP in the cytosol of hepatocytes [2]. Zn*+ 
has, on the other hand, been shown to be highly toxic to cell 
cultures, and is taken up by the cells by Ca’+ channels or, when 
bound to transferrin, via the transferrin receptor [3]. In cells 
and in vitro Zn2’ inhibits mitochondrial respiration [4] at differ- 
ent points in Complex III of the respiratory chain depending 
on the amount of Zn2’ [4-71. In rat liver mitochondria there is 
a high-affinity binding site for Zn2’ with a KD of 1 ,uM when 
respiratory chain components are reduced [6]. Like other 
SH-group reagents, Zn” promotes energy-dependent uptake of 
Mg2’ [8,9] and K’ in heart mitochondria if they are present in 
the medium, and induces mitochondrial swelling [9,10]. Zn2’ 
also promotes binding of the inhibitory subunit IF, to the ATP 
synthase (EC 3.6.1.34) without causing inhibition of the enzyme 
1111. 
Little is known about the mechanism of transport of Zn2’ 
into mitochondria. Zn2’ uptake has been reported for rat liver 
mitochondria [l]. There were no specific inhibitors known for 
mitochondria Ca2’ transport when the early studies cited above 
were carried out. Zn2+ was reported to inhibit the uptake of 
Ca2’ by frog skeletal muscle mitochondria [12]. Rouslin [l I] 
found Ruthenium red not to intluence the effect of Zn2’ on 
ATP synthase and concluded that it was not transported on the 
mitochondrial calcium uniporter. Indeed, heavy metal cations 
are frequently taken up by mitochondria in a non-specific way 
[13]. The uniporter has a rather low cation specificity (see re- 
view in [13]) determined largely by the ionic radius of the bi- 
or trivalent cation. Thus, the related Cd’+ with an ionic radius 
of 0.97 A, close to that of Ca2+ (0.99 A) [14], is transported by 
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the uniporter [15]. Zn2+, however, has an ionic radius of 0.74 
A that is closer to that of Me (0.66 A) which is not trans- 
ported. In this study Ruthenium red was found to inhibit the 
energy- dependent uptake of Zn2+ by mitochondria under ap- 
propriate conditions, which indicates that it may be transported 
by the calcium uniporter. 
2. Materials and methods 
Rat liver mitochondria were prepared by a conventional differential 
centrifugation method as described elsewhere [16], their protein content 
was measured by the Lowry procedure [17] with bovine serum albumin 
as a standard, and respiration was followed polarographically. Changes 
in [Zn2+] were followed with the metallochromic indicator antipyrylazo 
III (Fluka AG, Buchs, Switzerland; concentration, 50 PM) employing 
the wavelength couple 675690 nm [18]. Ca2’ transport was followed 
by the same technique or with the aid of %a [19]. Safranin at a 
concentration of 50pM was used as a probe of the membrane potential 
[20] with the wavelength pair 554524 mn. Incubations were carried out 
at room temperature (22-23°C) in a medium containing 0.25 M su- 
crose, 2 mM MgCl,, 1 mM KH2P04, 4 mM Tris-succinate and 6 PM 
rotenone, the pH being adjusted to 7.4 with Tris-base, and suspension 
density being 0.7 mg protein/ml, if not otherwise mentioned in the 
legends. 
3. Results and discussion 
3.1. Zn2+ inhibits Ca2+ uptake by lowering the membrane 
potential 
Fig. 1 shows the potent inhibition by Zn” of the uptake of 
Ca” by mitochondria respiring on succinate. This confirms 
earlier reports [12]. This effect may be due to an effect on the 
calcium uniporter or to an effect of Zn” on the transmembrane 
potential that drives the uptake of Ca2+ on the uniporter. The 
inhibitory effect of Zn2+ on Ca2’ uptake was smaller in the 
presence of low amounts of CaZ’, which rather points to an 
effect upon the membrane potential. Indeed, Zn2+ decreased the 
apparent membrane potential when the mitochondria were re- 
spiring on succinate (Fig. 2A). In contrast, Zn2+ had little, if 
any, effect on the valinomycin-induced generation of mem- 
brane potential or its decay (Fig. 2B). This indicates that the 
inhibition of net Ca” uptake by Zn” is not due to stimulated 
efflux or induction of a permeability transition but could be due 
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Fig. 1. Inhibition of Ca’+ uptake by Zn”. Uptake was measured by the 
radioisotope method with sampling at 15 s. The rate of the control 
without Zr?’ is taken as 100%. Ca” concentrations, (1) 80 PM; (2) 
40 PM; (3) 20 PM and (4) 10 PM. 
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Fig. 2. Effect of Zn” on the membrane potential. Decrease in mem- 
brane potential causes a downward deflection. In A the experimental 
conditions correspond to those in Fig. 1. In B membrane potential was 
induced by addition of 0.4 PM valinomycin in a medium in which K’ 
was replaced by Na’ and succinate omitted. The amount of Zn” was, 
(1) 0; (2) 1 PM; (3) 4 PM and (4) 10 PM. Mitochondria, 0.5 mg ., I. 
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Fig. 4. Zn” does not influence efllux of Ca2’ or the cyclosporin A- 
sensitive pore. The concentration of Mg2+ was 5 mM, and 5 mM 
Tris-phosphate was present. The different marks correspond to 0, 1, 2, 
4 and 10 PM Zn*‘. At the arrow Ruthenium red (RR) and Zn2’ were ^ _ . . . . 
added. In the upper trace (+) 0.5 rig/ml cyctosponn A was present. 
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Fig. 3. Zn2+ does not inhibit Ca” uptake driven by the membrane 
potential. The experimental conditions correspond to those in Fig. 2B. 
Addition of 20 PM Ca” was followed by its slow uptake that was 
inhibited in the presence of 6pM Zn2’. Addition of valinomycin caused 
fast uptake of the Ca*‘. 
to the inhibition of respiration and generation of membrane 
potential. Thus, when CaZC uptake was driven by valinomycin- 
induced membrane potential, added Ca” was readily taken up 
also in the presence of Zn2’ which, however, inhibited the 
uptake prior to the addition of valinomycin, i.e. that driven by 
respiration on endogenous ubstrates (Fig. 3). The Ruthenium 
red-insensitive fflux rate of Ca” was not influenced by Zn*’ 
but was inhibited in the presence of cyclosporin A (Fig. 4). This 
confirms the finding of Fig. 2B that Zn” does not cause a 
permeability transition. 
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Fig. 5. Inhibition of Zn” uptake by Ruthenium red. The rat liver 
mitochondria were respiring on succinate. Addition of 20 PM Zn” 
caused a downward deflection followed by a slow upward deflection of 
the trace, indicating uptake of the cation. This was prevented by Ruthe- 
nium red. RR. 
3.2. Inhibition of Zn2+ uptake by Ruthenium red 
Fig. 5 shows a trace of Zn” uptake and its inhibition by 
Ruthenium red. In a control experiment, the uptake of Ca2’ 
was followed by the radioisotope method using 4sCa. No 
changes in Ca2’ were found after the addition of Zn2’ (not 
shown). This shows that the upper trace indeed represents an 
uptake of Zn2+, and not Ca2’, on the uniporter. 
From these findings it could be expected that the effect of 
Zn*’ on the membrane potential generated by succinate respira- 
tion would be prevented by Ruthenium red. However, Ruthe- 
nium red did not prevent the drop in membrane potential 
caused by addition of 1 or 10 PM Zn” (data not shown). This 
was true also when Mg2’ was omitted and K’ replaced by Na+, 
i.e. in the absence of cations the transport of which is stimulated 
by Zn”. The situation is analogous to the finding of Rouslin 
197 
[l l] in that Ruthenium red did not prevent the effects of Zn” 
on the binding of the inhibitory subunit to ATP synthase. 
Either the Zn2’-binding sites involved in these effects are acces- 
sible to Zn2+ from the cytosolic side or there are other transport 
mechanisms for Zn” than the calcium uniporter. Considering 
the closeness of the ionic radii of Mg2+ and Zn2’ it is conceiv- 
able that these two cations could be transported by the same 
mechanism. The trace of Zn2’ uptake in the presence of Ruthe- 
nium red in Fig. 5 does not exclude uptake of some Zn” 
immediately following its addition but would not differentiate 
this from a binding to external sites. The experiment hus does 
not support a significant ransport of Zn2+ by other pathways. 
3.3. Modulation of Zn2+ uptake by Ca” 
Fig. 6 shows experiments in which varying amounts of Zn” 
followed by 40 PM Ca2’ were added to mitochondria respiring 
on TMPD and ascorbate. The uptake of at least the higher 
amounts of Zn2+ had not yet reached a steady state before the 
addition of Ca2’. Ca” was quickly taken up by the mitochon- 
dria but the traces continued above the level existing prior to 
the addition of Ca2’. This indicates stimulation by CaZC of the 
uptake of Zn2’. In a control experiment using the highest 
amounts of Zn2+, Ruthenium red was added simultaneously 
with Ca2+ (trace 6). Comparing this trace with the correspond- 
ing trace without the inhibitor (trace 5) reveals that the stimu- 
lated uptake is mainly due to the uniporter being sensitive to 
Ruthenium red. In the control experiment (trace 1) without 
addition of Zn2+, there is only a slight overshoot. These data 
show that Ca” may greatly enhance the uptake of Zn2’ on the 
calcium uniporter. This is analogous to the stimulation of the 
uptake of Ca” by Ca” itself [21] that may lead to an overshoot 
in the uptake [22]. 
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Fig. 6. Car’ stimulates the uptake of Zn*’ driven by respiration of 
TMPD + ascorbate. Varvina amounts of Zn” were present and had 
partly been taken up: (trace-l) 0 ,uM; (2) 5 PM; (3) ld,~M; (4) 20 PM; 
(5) 40 ,uM, and (6) 20 ,uM Zn*+ and Ruthenium red. The addition of 
Ca” was at 40 ,uM. The concentration of ascorbate was 2 mM and of 
TMPD 0.4 mM. 
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